← Founder Notes
Archive

The first ai-designed drug has entered a phase iii trial

Yethikrishna ROriginal on Threads

the first ai-designed drug has entered a phase iii trial: insilico’s rentosertib started a 320-patient study for pulmonary fibrosis in august. the molecule came from the company’s generative chemistry engine, not a human hypothesis.

the field’s real test is whether the next one clears the fda.

Provenance

The note above is reproduced unedited from the original post, first published on Threads on 1 October 2026 at 11:40 IST.

View the original post
Embed this note
<iframe src="https://founder.myndlabs.tech/notes/embed/the-first-ai-designed-drug-has-entered-a-Dd8O-a4jFsk" width="480" height="420" style="border:0;max-width:100%" loading="lazy" title="The first ai-designed drug has entered a phase iii trial"></iframe>

More notes